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Abstract. 
 
Aminopeptidase I (API) is transported into 
the yeast vacuole by the cytoplasm to vacuole targeting 
(Cvt) pathway. Genetic evidence suggests that auto-
phagy, a major degradative pathway in eukaryotes, and 
the Cvt pathway share largely the same cellular ma-
chinery. To understand the mechanism of the Cvt im-
port process, we examined the native state of API. 
Dodecameric assembly of precursor API in the cyto-
plasm and membrane binding were rapid events, 
whereas subsequent vacuolar import appeared to be 
rate limiting. A unique temperature-sensitive API-tar-
geting mutant allowed us to kinetically monitor its oli-
gomeric state during translocation. Our findings indi-
cate that API is maintained as a dodecamer throughout 
its import and will be useful to study the posttransla-
tional movement of folded proteins across biological 
membranes.
 
T
 
he
 
 faithful transport of resident organellar proteins
is a hallmark in maintaining the functional charac-
teristics and integrity of eukaryotic cells. All nuclear-
encoded proteins delivered to their respective organelles
must cross at least one membrane barrier. Posttrans-
lational delivery of proteins into membrane compartments
occurs by three known mechanisms: a protein-conducting
channel, as observed for example in the import of proteins
into mitochondria and ER (Pfanner and Neupert, 1990;
Hannavy et al., 1993; Egner et al., 1995; Rapoport et al.,
1996); a large nuclear pore–like complex (Davis, 1995;
Görlich and Mattaj, 1996); and by vesicle-mediated trans-
port and fusion events (Rothman and Wieland, 1996). The
conformational state of proteins during this translocation
step limits and defines the possible mechanisms by which
proteins can be delivered to their final destination.
Proteins arrive at their respective organelles in either a
partially unfolded state or a fully folded conformation.
Most proteins enter the ER cotranslationally, while those
that cross the membrane after synthesis assume an ex-
tended conformation to pass through the translocation
complex in the ER membrane (Rapoport et al., 1996).
Most mitochondrial proteins enter the organelle post-
translationally and must assume a partially unfolded state
before translocation across the membrane through a pro-
teinaceous channel (Hannavy et al., 1993; Hachiya et al.,
1995; Ryan and Jensen, 1995). Small monomeric proteins
or peptides may also be translocated across membranes
through ATP binding cassette transporters (Egner et al.,
1995). No proteins are known to enter the vacuole cotrans-
lationally, and a protein-conducting channel has not been
identified in the vacuole membrane.
A vacuolar version of a channel equivalent to the nu-
clear pore complex would allow the passage of folded pro-
teins into the vacuole lumen. However, there is no mor-
phological evidence for such pore complexes on the vacuole
membrane. Furthermore, the vacuole maintains a mem-
brane potential through the action of a vacuolar ATPase
(Klionsky et al., 1990). The corresponding requirement for
a sealed membrane would preclude such pore complexes
from existing on the vacuole.
In contrast to the extended conformation used by pro-
teins imported into mitochondria and ER, conformational
studies of peroxisomal proteins revealed that substrates
destined for this organelle can enter the peroxisomal ma-
trix in a fully folded state. In fact, large, preassembled oli-
gomeric complexes can be imported into the peroxisomal
lumen (Subramani, 1993; Rachubinski and Subramani,
1995). The dimeric thiolase, CAT trimers, and alcohol oxi-
dase octamers all serve as substrates for import into the
peroxisome (Walton et al., 1992; Glover et al., 1994; Mc-
New and Goodman, 1994). The lack of ideal marker pro-
teins that undergo proteolytic maturation steps, however,
has complicated the analysis of this pathway. Accordingly,
whether peroxisomal substrates enter the organelle by a
translocation pore or through a vesicular mechanism re-
mains to be resolved.
The majority of resident vacuolar proteases are trans-
ported posttranslationally via part of the secretory path-
way. Upon vacuolar delivery, most of these hydrolases are
processed by cleavage of a propeptide region to produce
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the active mature form of the enzymes. In contrast, ami-
nopeptidase I (API)
 
1
 
 is delivered to the vacuole by the
nonclassical cytoplasm to vacuole targeting (Cvt) pathway
(Klionsky et al., 1992; Harding et al., 1995). After synthe-
sis as a cytosolic 61-kD precursor, API becomes proteolyt-
ically processed in the vacuole by the removal of its NH
 
2
 
-ter-
minal propeptide, resulting in the 50-kD mature protease
(Klionsky et al., 1992). Thus, the molecular mass shift of
API upon vacuolar delivery serves as a useful marker for
correct import. Using this criterion, a set of mutants (
 
cvt
 
)
defective in API processing was recently isolated (Harding
et al., 1995, 1996). Surprisingly, the 
 
cvt
 
 mutants show ex-
tensive genetic and phenotypic overlap with two sets of
mutants defective in autophagy, 
 
apg
 
 and 
 
aut
 
 (Tsukada and
Ohsumi, 1993; Thumm et al., 1994), which suggests that
the Cvt pathway and the autophagy pathway use much of
the same cellular machinery (Harding et al., 1996; Scott et
al., 1996).
The study of the mechanism of API import promises to
contribute to our understanding of the basic processes of
not only the Cvt pathway but also autophagy. Autophagy
plays a central role in protein and organelle turnover in all
eukaryotic cells by delivering cytoplasmic components to
the lysosome/vacuole. In addition, autophagy has been im-
plicated in cellular remodeling during development and
differentiation and removal of damaged cellular compo-
nents, and is critical for survival during stress conditions
such as nutrient deprivation (Glaumann et al., 1981; Mar-
zella and Glaumann, 1987; Mortimore et al., 1989; Hilt and
Wolf, 1992; Egner et al., 1993; Dunn, 1994). Despite the
genetic overlap between the autophagy and 
 
cvt
 
 mutants,
some distinctions between the pathways are still apparent.
Whereas bulk autophagy is a nonselective, degradative
pathway, the delivery of API is a selective, biosynthetic
process. Similarly, vacuolar protein uptake by bulk au-
tophagy is relatively slow and cannot account for the rapid
kinetics of API import (Egner et al., 1993; Knop et al.,
1993; Scott et al., 1996). Finally, import of API is constitu-
tive, occurring under vegetative growth as well as starva-
tion conditions.
The molecular components and mechanisms of both au-
tophagy and the Cvt pathway remain to be elucidated. In
this study, we examined the oligomerization state of API
during its import process to understand how it enters the
vacuole. Previous studies have indicated that API exists in
the vacuole as a dodecamer of identical subunits (Metz et al.,
1977; Löffler and Röhm, 1979). We hypothesized that ex-
amining the kinetics of API assembly and transit through
the Cvt pathway would offer insight into the question of
whether large oligomeric complexes are imported into the
vacuole as well as elucidating possible intermediate steps
of the biosynthetic Cvt pathway. Further, we used a unique
API-targeting mutant that allowed us to kinetically examine
the assembly state of API during the membrane crossing
event. Our findings indicate that precursor API is rapidly
oligomerized into a dodecameric complex that is sub-
sequently transported into the vacuole without disassembly.
 
Materials and Methods
 
Strains and Media
 
The 
 
Saccharomyces cerevisiae
 
 strains used in this study were SEY6210,
 
MAT
 
a
 
 
 
leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 suc2-
 
D
 
9 GAL
 
 and
SEY6211, 
 
MAT
 
a
 
 
 
leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 ade2-101 suc2-
 
D
 
9 GAL
 
 (Robinson et al., 1988); DYY101 
 
MAT
 
a
 
 
 
leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 suc2-
 
D
 
9 GAL ape1
 
D
 
::LEU2
 
 (Klionsky et al.,
1992); THY101 
 
MAT
 
a
 
 
 
leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801
suc2-
 
D
 
9 GAL ape1
 
D
 
::LEU2
 
 (Oda et al., 1996).
 
cvt
 
 strains 
 
1
 
 to 
 
17
 
 were derived from SEY6210 and SEY6211 (Harding
et al., 1995, 1996). The plasmid construction of the API propeptide dele-
tions (
 
D
 
3–5
 
, 
 
D
 
6–8
 
, 
 
D
 
9–11
 
, 
 
D
 
12–14
 
, 
 
D
 
15–17
 
, 
 
D
 
18–20
 
, 
 
D
 
25–27
 
, 
 
D
 
28–30
 
, 
 
D
 
31–
33
 
, 
 
D
 
34–36
 
, 
 
D
 
37–39
 
, 
 
D
 
40–42
 
, 
 
D
 
2–45
 
) and the K12R API mutation were de-
scribed previously (Oda et al., 1996). The propeptide deletion mutation
plasmids were introduced into strain DYY101, while the K12R mutant
was transformed into strain THY101.
 
Reagents
 
The Vistra enhanced chemifluorescence (ECF) Western Blotting System
was obtained from Amersham Corp. (Arlington Heights, IL); oxalyticase
was from Enzogenetics (Corvallis, OR); Express
 
35
 
S
 
35
 
S-label was from Du-
pont/NEN Research Products (Boston, MA); proteinase K, Pefabloc, and
the molecular mass standards used for the native gel and glycerol gradient
analyses were obtained from Boehringer Mannheim Corp. (Indianapolis,
IN); Sulfo-NHS-Biotin and avidin agarose were from Pierce (Rockford,
IL); all other reagents were from Sigma Chemical Co. (St. Louis, MO).
Antisera against the following proteins were prepared as described previ-
ously: API (Klionsky et al., 1992), carboxypeptidase Y (CPY) and pro-
teinase A (PrA) (Klionsky et al., 1988), and alkaline phosphatase (ALP)
(Klionsky and Emr, 1989); antiserum against phosphoglycerate kinase
(PGK) was provided by Dr. Jeremy Thorner (University of California,
Berkeley, CA) (Baum et al., 1978).
 
Preparation of Crude Cell Extracts, Spheroplasting, 
Cell Fractionation, and Labeling
 
Labeling of whole cells has been described previously. In brief, cells were
grown to an OD
 
600
 
 of 1 and resuspended in synthetic minimal medium
(SMD; 0.067% yeast nitrogen base, 2% glucose, and auxotrophic amino ac-
ids and vitamins as needed) at 20–30 OD
 
600
 
/ml. The resuspended cells
were labeled with 10–20 
 
m
 
Ci of 
 
35
 
S Express label/OD
 
600
 
 for the indicated
times and temperatures, followed by a chase reaction in which the labeled
cells were diluted to 1 OD/ml in SMD supplemented with 0.2% yeast ex-
tract, 4 mM methionine, and 2 mM cysteine.
For preparation of crude cell extracts used for glycerol gradient analy-
sis, 5–15 OD
 
600
 
 units of labeled or unlabeled cells were resuspended in 300 
 
m
 
l
of 20 mM K-Pipes, pH 6.8, containing a cocktail of protease inhibitors (10
mM benzamidine, 4 mM Pefabloc or 2 mM PMSF, 2 
 
m
 
g/ml pepstatin, and
10 mM NaN
 
3
 
). Acid-washed glass beads were then added to a level 50%
of the resuspended cell volume. The cell suspension was lysed by vortex-
ing for 1 min, and the cell extract was collected after a 3-min centrifuga-
tion at 12,000 
 
g.
 
Spheroplasts were prepared using a modified procedure of one previ-
ously described (Klionsky et al., 1992). Cells were grown in SMD to an
OD
 
600
 
 of 1 and incubated for 15 min at 30
 
8
 
C in a buffer of 0.1 M Tris-SO
 
4
 
,
pH 9.4, 10 mM DTT. After a 5,000-
 
g
 
 spin for 5 min, the cells were resus-
pended in an osmotically supportive spheroplast labeling medium (1 M
sorbitol, 1% glucose, 1% proline, Wickerham’s salts, pH 7.5 [Guthrie and
Fink, 1991]), containing 1 
 
m
 
g/OD
 
600
 
 of oxalyticase and incubated for 30
min at 30
 
8
 
C. After a 5-min spin at 3,000 
 
g
 
, the spheroplasts were resus-
pended in fresh spheroplast labeling medium, pH 5.0, at 20–50 OD
 
600
 
/ml
and labeled with 10–20 
 
m
 
Ci of 
 
35
 
S Express label/OD
 
600
 
 for 5–10 min at the
indicated temperatures. The labeling reaction was chased by diluting the
spheroplasts to 1–3 OD
 
600
 
/ml in SMD supplemented with 0.2% yeast ex-
tract, 1 M sorbitol, 4 mM methionine, and 2 mM cysteine for the times and
temperatures indicated.
Subcellular fractionations of spheroplasts by differential osmotic lysis
has been described previously (Scott and Klionsky, 1995). The pellet frac-
 
1. 
 
Abbreviations used in this paper
 
: ALP, alkaline phosphatase; API, ami-
nopeptidase I; CPY, carboxypeptidase Y; Cvt, cytoplasm to vacuole tar-
geting; ECF, enhanced chemifluorescence; PGK, phosphoglycerate ki-
nase; PrA and PrB, proteinase A and B; SMD, synthetic minimal medium
containing 2% glucose, essential amino acids and ammonium sulfate. 
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tion was resuspended in 20 mM K-Pipes, pH 6.8, with protease inhibitor
cocktail to release the vacuolar lumenal contents as well as to release API
bound to the pellet.
 
Protease Studies
 
Spheroplasts of the THY101 (
 
ape1
 
D
 
) strain harboring the K12R API sin-
gle copy plasmid were labeled for 5 min, followed by a chase reaction for
30 min at 38
 
8
 
C. The labeled spheroplasts were subjected to differential os-
motic lysis in import buffer (20 mM K-Pipes, pH 6.8, 100 mM sorbitol, 100
mM KCl, 50 mM KOAc, 5 mM Mg[OAc]
 
2
 
). Permeabilized cells were then
fractionated by centrifugation at 5,000 
 
g
 
 for 3 min, resulting in a superna-
tant fraction and a pellet fraction that was then resuspended in import
buffer. The pellet fraction contains intact vacuoles (Scott and Klionsky,
1995). The fractions were treated with 100 
 
m
 
g/ml proteinase K alone, or
with the addition of 0.2% Triton X-100 for 15 min, on ice. Nonradioactive
pellet and supernatant fractions were added to the labeled supernatant
and pellet samples, respectively, to keep the protein concentration con-
stant during the protease digestion procedure and subsequent protein re-
covery steps.
 
Biotinylation Studies
 
Spheroplasts were subjected to pulse/chase analysis and subcellular frac-
tionation exactly as in the protease protection experiment above. The pel-
let fraction (from 5 OD
 
600
 
 of radiolabeled spheroplasts) was resuspended
in 500 
 
m
 
l of import buffer (pH adjusted to 7.4) containing 0.5 mg/ml Sulfo-
NHS-Biotin in the presence or absence of 0.2% Triton X-100. The sam-
ples were incubated for 20 min at room temperature. The reaction was
quenched by the addition of 100 mM Tris-Cl, pH 7.5, followed by precipi-
tation with 10% trichloroacetic acid. Proteins were recovered by immuno-
precipitation with antibodies against API and CPY followed by recovery
on avidin agarose beads (Scott and Klionsky, 1995). Nonradioactive pellet
and supernatant fractions were added to the labeled supernatant and pel-
let samples, respectively, to keep the protein concentration constant dur-
ing the cross-linking and protein recovery procedures.
 
Glycerol Gradients, Immunoprecipitations, and
Western Blotting
 
For gradient analysis, 200 
 
m
 
l of cell extracts or fractionated spheroplast
samples were loaded on a 1.8-ml, 20–50% glycerol step-gradient prepared
in 20 mM K-Pipes, pH 6.8, with a cocktail of protease inhibitors. The gra-
dients were spun in a centrifuge (model TL-100; Beckman Instrs., Fuller-
ton, CA) for 4 h at 270,000 
 
g
 
, and at 15
 
8
 
C using a TLS-55 rotor (Beckman
Instrs.). Fractions were collected from the top of the gradients and immuno-
precipitated as previously described (Klionsky et al., 1992). The Western
blotting procedure described previously (Oda et al., 1996) was modified
and immunodetection was executed using a Vistra ECF chemifluorescent
substrate (Amersham Corp.). Identical gradients were run with a mixture
of molecular mass standards consisting of ovalbumin (45 kD), aldolase
(158 kD), catalase (240 kD), apoferritin (450 kD), and thyroglobulin (669
kD); the collected fractions were precipitated as described above and sub-
jected to SDS-PAGE and Coomassie brilliant blue staining.
Quantitation of immunoprecipitations and Western blots was per-
formed using a phosphorimager (model Storm; Molecular Dynamics,
Sunnyvale, CA) equipped with both phosphorescent and chemifluores-
cent scanning capabilities.
 
Native Gel Sample Preparation and Electrophoresis
 
Sample preparation, native gel electrophoresis, and Hedrick-Smith analy-
sis procedures have been previously described in detail (Hedrick and
Smith, 1968; Tomashek et al., 1996).
 
Results
 
Precursor and Mature API Are Both Dodecamers in 
Steady-State Conditions
 
The native state of API was examined by glycerol density
gradients and native gel electrophoresis. Cell extracts were
prepared from wild-type cells and separated on 20–50%
glycerol density gradients as described in Materials and
Methods. After centrifugation, the proteins in the col-
lected fractions were precipitated and subjected to West-
ern blot analysis. Under steady-state conditions, the ma-
jority of API in wild-type cells exists as the processed,
mature form of the molecule. However, when cells were
grown to midlog phase, a small population of precursor
API could also be detected (Fig. 1 
 
A
 
). The peak concen-
trations of both precursor and mature API appeared in
fraction 7 of the gradient (Fig. 1 
 
A
 
), cofractionating with
the 669-kD molecular mass standard, thyroglobulin. This
finding is consistent with the dodecameric stoichiometry
of mature API subunits (12 
 
3
 
 50 kD 
 
5
 
 600 kD) that was
proposed previously (Metz et al., 1977; Löffler and Röhm,
1979). In addition, the appearance of precursor API in
fraction 7 suggests that it also forms a dodecameric com-
plex (12 
 
3
 
 61 kD 
 
5
 
 732 kD). To confirm that these large
complexes were in fact API homooligomers, cross-linking
studies were performed using radiolabeled cell extracts.
As before, precursor API-containing cross-linked prod-
ucts were recovered from fraction 7 of glycerol gradients
(data not shown). On reduction of the cross-link, only API
was detected, suggesting that the API oligomer recovered
from fraction 7 is a homooligomer. These data do not rule
out the possibility, however, that other proteins transiently
associate with the API oligomer.
To obtain a separate estimation of the molecular mass
of the API oligomer, native gels were run and analyzed by
the Hedrick-Smith method (Hedrick and Smith, 1968; To-
mashek et al., 1996). Native gels ranging from 4 to 5.5%
acrylamide were run on extracts from wild-type and 
 
pep4
 
D
 
strains, and the relative mobilities of both mature and pre-
cursor API were measured. Molecular mass standards were
run on the same gels, blotted, and stained with Amido black
as cited in Materials and Methods. The relative mobilities
were plotted as a function of gel percent and the negative
slopes of these graphs were then plotted as a function of
molecular mass (Fig. 1 
 
B
 
). The molecular masses of ma-
ture API from a wild-type strain and precursor API from a
 
pep4
 
D
 
 strain were determined to be 592 and 752 kD, re-
spectively, consistent with the predicted molecular mass of
600 kD for the mature API dodecamer and 732 kD for the
dodecameric precursor hydrolase (Fig. 1 
 
B
 
). Because the
native gel electrophoresis analyses were in close agree-
ment with the glycerol gradient results, subsequent kinetic
studies were performed using the gradient method.
 
Oligomerization of Precursor API Is an Early Step in
Its Import
 
The half-time of API import and processing is 30–45 min
(Klionsky et al., 1992). We wanted to determine the point
during biosynthesis at which API oligomerization occurs.
To observe the oligomerization process in vivo, whole cells
were labeled for 2 min, followed by chase reactions of 0, 3,
6, and 10 min with excess cold methionine and cysteine.
After each chase point, the labeled cells were immediately
lysed with glass beads and centrifuged for 1 min to remove
cellular debris, and the extracts were separated on 20–50%
glycerol density gradients. Fractions were collected from
the gradient and analyzed by immunoprecipitation. Oligo- 
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merization did not appreciably occur after cell lysis (data not
shown), presumably because of the resulting substantial
dilution.
After a 2-min pulse without a chase, the majority of la-
beled precursor API was recovered in fractions 2 and 3, con-
sistent with the size of the precursor API monomer (61 kD;
Fig. 2, 
 
top panel
 
). Interestingly, even at this early time
point, a small peak at fraction 7 corresponding to oligo-
meric precursor could be detected. After a 3-min chase,
the relative distribution of precursor API monomer and
oligomer was reversed, with the majority of the labeled
precursor API assembling into the oligomeric form and
the concomitant depletion of the labeled monomer (Fig. 2,
 
second panel
 
). Oligomerization of labeled precursor API
was nearly complete after 6 min of the chase reaction, and
no monomer was detected after 10 min of chase (Fig. 2,
 
third and fourth panels
 
, respectively). These data indicate
a half-time of oligomerization of 
 
z
 
2 min. Therefore, the in
vivo kinetics of precursor API oligomerization are far
more rapid than the half-time of API maturation, suggest-
ing that oligomer assembly is an early step in the import of
API into the vacuole.
 
Precursor API Oligomerizes in the Cytoplasm and Then 
Binds to a Membrane
 
To determine the subcellular location of precursor API
Figure 2. Oligomerization kinetics of precursor API. Wild-type
cells were pulse labeled for 2 min at 308C followed by nonradio-
active chase reactions. Aliquots were removed at the indicated
chase times and lysed with glass beads, and the resulting cell ex-
tracts were separated on 20–50% glycerol gradients. Fractions
were collected, immunoprecipitated with antiserum to API, and
resolved by SDS-PAGE. Molecular mass standards correspond-
ing to the fractions: 45 kD, fraction 2; 158 kD, fraction 4; 240 kD,
fraction 5; 450 kD, fraction 6; and 669 kD, fraction 7. Quantita-
tion of the radioactive signals was performed using a phosphor-
imager (model Storm; Molecular Dynamics).
Figure 1. Molecular mass determination of native precursor and
mature API under steady-state conditions. (A) Glycerol gradient
analysis of precursor and mature API under steady-state condi-
tions. Wild-type (SEY6210) cells were grown to midlog phase,
lysed with glass beads, and the resulting cell extracts were sepa-
rated on 20–50% glycerol gradients. Collected fractions were sub-
jected to Western blotting with antiserum to API. The reaction of
a chemifluorescent substrate (ECF) with an alkaline phosphatase–
conjugated secondary antibody allowed for the quantitation of
the Western blots by a chemifluorescence scanner (Molecular
Dynamics) as shown in the graph corresponding to the Western
blot signals. Molecular mass standards indicated are hen egg albu-
min (45 kD), aldolase (158 kD), catalase (240 kD), ferritin (450 kD),
and thyroglobulin (669 kD). Both mature (mAPI) and precursor
API (prAPI) peaks appeared in fraction 7, cofractionating with
the thyroglobulin molecular mass standard. (B) Hedrick-Smith
calculation of the molecular masses of precursor and mature API.
Relative mobilities were measured for protein standards resolved
on native gels of 4.0 to 5.5% acrylamide and the negative slopes
were determined by plotting the relative mobilities as a function
of gel percentage. A standard curve was then generated by plot-
ting the negative slopes of the protein standards as a function of
molecular mass. Extracts from wild-type and pep4D strains were
run on the same gels, and their molecular masses were calculated
with reference to the standard curve. Molecular masses of mAPI
and precursor API were determined to be 592 and 752 kD, re-
spectively. 
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oligomerization, subcellular fractionation experiments were
performed. Cells were converted into spheroplasts, la-
beled for 5 min, chased for 3 min, and subjected to a differ-
ential osmotic lysis procedure that disrupts the plasma
membrane while preserving the integrity of the vacuole
(Scott and Klionsky, 1995). Subsequent centrifugation re-
sulted in a cytosolic supernatant fraction and an organellar
membrane fraction that included the unlysed vacuoles.
The faithful segregation of vacuolar markers (ALP and
PrA, vacuolar membrane and lumenal hydrolases, respec-
tively) to the pellet fraction and a cytosolic marker (PGK)
to the supernatant fraction indicated the efficiency of this
subcellular fractionation procedure (Fig. 3 A).
Under these identical labeling and chase conditions, both
the precursor API monomer and dodecamer were de-
tected (Fig. 3 B). After subcellular fractionation, the la-
beled supernatant and resuspended pellet fractions were
separated by 20–50% glycerol gradients and examined by
immunoprecipitation. Monomeric precursor appears only
in the supernatant fraction along with the fully assembled
oligomeric precursor, suggesting that the API assembly
process occurs in the supernatant fraction containing the
released cytoplasm (Fig. 3 B). In contrast, primarily the
oligomeric precursor was detected in the pellet fraction
(Fig. 3 C). Furthermore, oligomeric precursor binding was
very rapid, as 51% of the precursor API dodecamer was
already bound to the membrane fraction after the 3-min
chase reaction. Previous experiments have shown that the
membrane-bound API is on the import pathway as it
chases into the vacuole in vitro (Scott and Klionsky, 1995).
These findings indicate that precursor assembly in the cy-
toplasm and subsequent membrane binding mark the
early steps of API import to the vacuole.
cvt and Propeptide Deletion Mutants Are Not Defective 
in API Oligomerization
The first amphipathic helix of the API propeptide is criti-
cal for proper targeting of the enzyme (Oda et al., 1996).
Specifically, deletions in this region inhibit API from bind-
ing to the membrane fraction, thus preventing subsequent
import and processing to the mature form (Oda et al.,
1996). We examined whether the targeting defect in these
propeptide deletion mutants was caused by an oligomer-
ization defect. Cell extracts were prepared from the DYY101
strain deleted for the gene encoding API (ape1D) but har-
boring a single copy plasmid encoding API with the pro-
peptide deletions. Western blot analysis of glycerol gradi-
ent fractions indicated that precursor API in all of the
propeptide deletion mutants peaked in fraction 7 (Fig. 4),
indicating that it was properly oligomerized. In addition,
an API molecule with a deletion of the entire propeptide
also formed API oligomers (data not shown). These re-
sults indicate that, while the propeptide is necessary for
binding to the membrane fraction and subsequent import
of API into the vacuole, it does not encode any sequence
determinants necessary for API oligomerization. In addi-
tion, these results demonstrate that dodecameric precur-
sor API assembly can occur in the absence of membrane
binding or transport to the vacuole, in agreement with the
kinetic and subcellular fractionation data (Figs. 2 and 3).
In addition to API propeptide mutants, we identified a
Figure 3. Oligomeric precursor API assembly occurs in the cyto-
plasm before membrane binding. Spheroplasts were labeled for 5
min at 308C followed by a 3-min nonradioactive chase reaction.
The samples were subjected to differential osmotic lysis and sepa-
rated into a supernatant fraction and a pellet fraction containing
intact vacuoles. An aliquot of the supernatant and pellet fractions
was removed and immunoprecipitated with the indicated anti-
sera, and the remainder was separated on 20–50% glycerol gradi-
ents. (A) Quantitation of the pellet fraction immunoprecipitated
with vacuolar markers PrA and ALP, and the cytosolic marker
PGK. The recovery of marker protein in the pellet was quantified
using a Storm phosphorimager. The percent recovery was calcu-
lated as the ratio of the protein in the pellet fraction to the pro-
tein in the pellet and supernatant fractions. The supernatant
(sup) fraction (B) and the pellet fraction (C) were separated on a
glycerol gradient and immunoprecipitated with antiserum to
API. Quantitation of the radioactive signals, represented by the
graphs, indicates that the supernatant fraction contains both the
precursor monomer and oligomer, while only the precursor API
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series of chromosomal mutants (cvt) that are defective for
API localization. The cvt mutants were isolated based on
their accumulation of precursor API (Harding et al., 1995,
1996). To examine if the localization defect in any of these
mutants was due to a failure in API oligomerization, cell
extracts of cvt 1 to 17 were examined by glycerol gradients
and Western blotting. Native precursor API from all of the
cvt mutants appeared in fraction 7 in glycerol density gra-
dients, consistent with correct precursor API assembly
(data not shown). These results suggest that cvt mutants
do not have defects in genes whose products are necessary
for API oligomerization.
A Unique Temperature-sensitive API
Propeptide Mutant (K12R) Accumulates in the 
Membrane Fraction
The oligomerization and membrane-binding steps of API
targeting appear early in the overall import process. We
next examined the oligomeric nature of API during the re-
mainder of the targeting steps. The membrane binding of
precursor API oligomer is followed by import into the vac-
uole and cleavage of the propeptide by proteinase B (PrB),
which yields mature API (Klionsky et al., 1992). To study
the oligomeric state of precursor API as it enters the vacu-
olar lumen from the membrane-bound state, we exploited
the unique characteristics of an API-targeting mutant in
which the twelfth lysine residue in the predicted amphi-
pathic helix of the propeptide was changed to an arginine.
The K12R point mutation rendered API defective for im-
port at nonpermissive temperature, 388C (Fig. 5 D, middle;
Oda et al., 1996), while wild-type kinetics were observed at
permissive temperature, 308C (Fig. 5 D, bottom).
To examine the localization of precursor API in the
K12R mutant at nonpermissive temperature, spheroplasts
were labeled for 10 min at 388C and chased from 0 to 2 h at
388C. At each chase time point, samples were separated
into supernatant and pellet fractions after differential os-
motic lysis and analyzed by immunoprecipitation. Over
the course of the chase period, the labeled precursor API
was depleted from the supernatant fraction and accumu-
lated in the pellet fraction (Fig. 5 A). The kinetics of mem-
brane binding were essentially identical for K12R API at
388C and the permissive temperature of 308C (data not
shown). Therefore, the unique targeting defect of the
K12R API mutation did not affect the membrane-binding
step, but rather a subsequent step in the import process.
The topology of K12R API accumulated at the mem-
brane-bound stage was examined by protease digestion
experiments. As above, labeled K12R API was allowed to
accumulate in the membrane fraction of spheroplasts by a
10-min labeling and a 30-min chase reaction at 388C. After
differential osmotic lysis, the supernatant and pellet frac-
tions were treated with proteinase K and examined by im-
munoprecipitation (Fig. 5 B). The vacuoles were shown to
be intact as the majority of the lumenal vacuolar hydrolase
CPY was localized in the pellet fraction, while the cytosolic
marker, PGK, was concentrated in the supernatant fraction
(Fig. 5 B, right). The majority of K12R API that accumu-
lated in the membrane fraction was accessible to protease
digestion, suggesting that the bound precursor API was
exposed to the cytoplasmic environment and not pro-
tected within a lumenal compartment (Fig. 5 B, left). The
small amount of precursor API remaining in the pellet
fraction after protease treatment is consistent with unlysed
spheroplasts that segregated to the pellet fraction (Fig. 5
B, right); this precursor API population was digested upon
addition of detergent (Fig. 5 B, left).
The results of the protease-protection experiment were
confirmed by assessing the accessibility of K12R API and
CPY recovered in the pellet fraction to modification by
Sulfo-NHS-biotin, a water-soluble cross-linker conjugated
to biotin. Proteins modified by this cross-linker can be spe-
cifically recovered by precipitation with avidin agarose
beads (Scott and Klionsky, 1995). When the pellet fraction
was treated with Sulfo-NHS-biotin, precursor K12R API
was recovered by avidin agarose regardless of whether de-
tergent was present during the cross-linking reaction (Fig.
5 C). In the same samples, biotinylation of mature CPY
and the small amount of mature API that escaped the tem-
perature block required the vacuoles to be solubilized by
detergent before the addition of cross-linker. Together
with Fig. 5 B, these results indicate that the K12R precur-
sor API that accumulates at 388C is not in the vacuole,
where it would be protected from both protease digestion
and biotinylation. The fact that the mutant precursor is ac-
cessible to biotinylated cross-linker, while mature vacuolar
hydrolases are not, suggests that it accumulates in a mem-
brane-bound state that is exposed to the cytosolic environ-
ment before vacuolar delivery.
To determine if the K12R import block was thermally
reversible, temperature shift experiments were performed.
Cells were labeled for 10 min and chased for 30 min at
388C to accumulate K12R precursor API on the mem-
brane. These cells were then shifted to 308C for various
lengths of time before immunoprecipitation (Fig. 5 D,
top). After 20 min at the permissive temperature, essen-
Figure 4. API-targeting mutants are not defective in API oligo-
merization. Strain DYY101 (ape1D) harboring a single copy plas-
mid encoding the propeptide deletions was grown to midlog
phase, lysed with glass beads, and separated on a 20–50% glyc-
erol gradient. The D9–11 API deletion mutant shown here is a
representative example of the analysis of the cvt (1 to 17) and
propeptide deletion mutants (D3–5, D6–8, D9–11, D12–14, D15–
17, D18–20, D25–27, D28–30, D31–33, D34–36, D37–39, D40–42,
and D2–45). Collected fractions were subjected to Western blot-
ting with antiserum to API and the quantitation of the Western
blots (shown in the graph) was performed as in Fig. 1.Kim et al. Vacuolar Import of Dodecameric Aminopeptidase I 615
tially all of the API was still present as the precursor form.
However, between 20–40 min after the 308C shift (Fig. 5
D, top, two-headed arrow), maturation of API increased
from 10 to 56%. Thus, the thermal reversal of the target-
ing defect allowed nearly half of the labeled precursor API
to enter the vacuole and become processed to the mature
hydrolase between these two time points. Complete matu-
ration of the precursor API was observed after 90 min at
308C, whereas labeled cells maintained at 388C during the
shift phase of the experiment remained defective for im-
port (Fig. 5 D, middle). The thermal reversibility of the
K12R API indicated that it was on the authentic import
pathway.
The K12R ts Mutant Traces the Import of API 
Oligomer during the Last, Rate-limiting Stages of the 
Cvt Pathway
A key question that we wanted to address was the oligo-
meric nature of precursor API during the transport step.
The K12R API bound to the membrane at the nonpermis-
sive temperature represented a synchronized population
of labeled precursor, making it possible to follow its im-
port into the vacuole upon reversal of the accumulation
phenotype. Cells were labeled for 10 min and chased for
30 min at 388C to accumulate precursor API oligomers on
the membrane (Fig. 5 A). The labeled cells were then
shifted to 308C to reverse the block and allow precursor
API to chase into the vacuole. The oligomeric state of API
was examined during the 20–40 min window of the shift
phase, when nearly half of the accumulated precursor API
was chased into the vacuole and processed. Samples were
removed at 20, 27, 34, and 40 min of the 308C shift period
and analyzed by glycerol gradients and immunoprecipita-
tion. As expected, at the 20-min shift point all of the API
is present as the precursor form, and by 40 min we see
approximately half of the protein as the mature species
(Fig. 6). At all time points, however, we detected only the
oligomeric form of API, either as the precursor or mature
dodecamer recovered in fraction 7 of the glycerol gradi-
Figure 5. The membrane accumulation phenotype of the K12R API ts mutant is thermally reversible. (A) K12R API accumulates in the
pellet fraction at nonpermissive temperature. Spheroplasts were labeled for 10 min at 388C followed by nonradioactive chase. Aliquots
were removed at the indicated chase times and separated into supernatant (sup) and pellet fractions. Samples were immunoprecipitated
with antiserum to API, and the radiolabeled signals were quantitated. The percent radiolabeled precursor at a given chase point repre-
sents the ratio of precursor from each supernatant or pellet fraction to the total API combined in both fractions. (B) Protease accessibil-
ity of K12R API in the supernatant and pellet fractions. Spheroplasts were labeled for 5 min, chased for 30 min at 388C, and separated
into a supernatant and pellet fraction after differential osmotic lysis. The supernatant and pellet fractions were subjected to proteinase
K and Triton X-100 as indicated and immunoprecipitated with antiserum to API (left). An aliquot of the recovered pellet fraction was
also immunoprecipitated with antisera to the vacuolar marker CPY and the cytosolic marker PGK before protease treatment (right).
The percent of marker proteins recovered in the pellet fraction was calculated as described for Fig. 3. (C) Accessibility of K12R API in
the pellet fraction to cross-linking with Sulfo-NHS-biotin. Labeled spheroplasts were fractionated exactly as in B. The pellet fraction
was cross-linked with Sulfo-NHS-biotin (Biotin-X) in the presence or absence of Triton X-100. API and CPY were recovered by immu-
noprecipitation followed by precipitation with avidin agarose beads. (D) Thermal reversibility of the K12R membrane-accumulation
phenotype. The K12R API mutant was pulse-labeled for 10 min, chased for 30 min at 388C, and then shifted to 308C (top). Samples were
removed at the indicated times during the shift period at 308C and lysed with glass beads. The resulting cell extracts were immunopre-
cipitated with antiserum to API and resolved by SDS-PAGE. The double-headed arrow in the top panel marks the 20–40-min window
of time when mature API increases from 10 to 56% during the 308C shift. The K12R API strain was also pulse labeled, chased, and incu-
bated all at 388C (middle) or 308C (bottom) in this experiment.The Journal of Cell Biology, Volume 137, 1997 616
ents. The kinetic examination of import indicated that oli-
gomeric precursor API maintained its dodecameric state
during the period of transport from the membrane-bound
step to entry and processing in the vacuole (Fig. 6).
While we could not detect monomeric API during the
import process, it is possible that the signal for a mono-
meric translocation intermediate was below our detection
level. However, if such disassembly occurred, then the
API monomers would be exposed to the hydrolases of the
vacuole lumen before reassembly into oligomers. In addi-
tion, a protein that goes through a translocation pore
would probably assume a partially unfolded conformation
(Schatz and Dobberstein, 1996). To mimic this disassem-
bled state, we examined the protease susceptibility of newly
synthesized monomeric precursor API. Cells were labeled
for 2 min to yield predominantly monomeric API, lysed
with glass beads, and subjected to proteolysis. These ex-
periments indicated that monomeric API was completely
degraded even after a brief treatment with proteinase K
(data not shown), suggesting that newly synthesized API
monomers would not survive the hydrolytic environment
of the vacuolar lumen. In contrast, mature API is resistant
to proteinase K digestion (Oda et al., 1996). This result
provides additional support for our model that API is
maintained as a dodecamer throughout its transport to the
vacuole.
Discussion
Our study demonstrates that a large oligomeric protein is
capable of being imported into the vacuole in a biosyn-
thetic manner and suggests a possible mechanism of API
transport by the Cvt pathway. Examination of the oligo-
meric state of API during transport allowed us to dissect
this process into a number of discrete steps. Kinetic analy-
ses indicated that precursor API oligomerizes rapidly into
a homododecamer (Fig. 2) as the majority of precursor
monomers assembled into oligomers within the first 5 min
of the pulse-label/chase reaction. Subcellular fractionation
localized the precursor API assembly process to the cyto-
sol (Fig. 3 B). The subsequent membrane binding of the
oligomeric precursor API was also rapid, with over half
of the labeled precursor associating with the membrane
within this brief labeling and chase period. These results
demonstrate that the early steps of API import, oligomer-
ization and membrane association, are not rate limiting,
and the time required for these early steps constitutes only
a fraction of the time needed for API import and matura-
tion in the vacuole.
Steady-state analyses of the cvt and API propeptide de-
letion mutants indicated that neither encodes gene prod-
ucts or contains API sequence determinants necessary for
API oligomerization, respectively (Fig. 4). However, a K12R
point mutation in the propeptide resulted in a unique tar-
geting defect that was useful for our examination of the
later stages of API import.
The majority of the time required for API import was
invested in the transport of the enzyme into the vacuole
lumen from the membrane-bound state, indicating that
this stage of the import process is rate limiting. To study
this event, we exploited the novel targeting defect of K12R
API. This temperature-sensitive mutant accumulated the
oligomeric precursor at the membrane-associated step
(Fig. 5 A), with the hydrolase exposed to the cytoplasmic
milieu as determined by its accessibility to protease and bi-
otinylated cross-linker (Fig. 5, B and C). Furthermore, the
thermal reversibility of the targeting defect allowed us to
kinetically examine the oligomerization state of API during
the membrane transport event (Figs. 5 D and 6). Between
20–40 min of shift to the permissive temperature, nearly
half of the membrane-accumulated oligomeric precursor
was chased into the vacuole to the mature form (Fig. 5 D,
top). When the oligomeric state of API was examined dur-
ing this process, no disassembly of oligomeric precursor
API was observed (Fig. 6). These results strongly suggest
that the dodecameric precursor API maintains its oligo-
meric conformation throughout its import into the vacuole.
Oligomerization and membrane targeting do not appear
to be rate-limiting steps in API import. The efficient as-
sembly of the API dodecamer may require cytosolic chap-
erones for proper oligomerization as well as to prevent pro-
tein aggregation (Hartl, 1996; Jaenicke, 1996). We are
currently pursuing detailed cross-linking studies to isolate
possible transient API-associated cytosolic factors. Although
oligomerization appears to stabilize API from proteolytic
degradation (data not shown), a question that remains is
whether oligomerization itself is necessary for correct tar-
geting of the protein or for its enzymatic activity. Prelimi-
nary results suggest that the COOH terminus of API may
contain an oligomerization domain; truncations in this re-
gion render API incompetent for import and subsequent
processing in the vacuole (Oda et al., 1996). Although
these deletion mutants are also defective for oligomeriza-
tion (data not shown), the possibility that they are simply
misfolded cannot be ruled out.
Figure 6. Membrane-associated API is imported into the vacuole
as an oligomer. The K12R API mutant was pulse labeled for 10
min and chased for 30 min at 388C and then shifted to 308C. Sam-
ples were removed at the indicated times during the 20–40-min
window of the 308C shift period and lysed with glass beads, and
the resulting extract was separated by 20–50% glycerol gradients.
Fractions were collected, immunoprecipitated with antiserum to
API, and resolved by SDS-PAGE. Both mature (mAPI) and pre-
cursor API (prAPI) peaks appeared in fraction 7, cofractionating
with the thyroglobulin molecular mass standard (669 kD).Kim et al. Vacuolar Import of Dodecameric Aminopeptidase I 617
The target of the newly synthesized oligomeric precur-
sor is a membrane fraction containing intact vacuoles. How-
ever, whether the initial membrane binding of precursor
API oligomer occurs at the vacuole surface or perhaps at a
prevacuolar compartment remains to be resolved. Over-
production of precursor API causes the accumulation of
the cytosolic precursor, suggesting that there is a saturable
receptor for API import (Klionsky et al., 1992). Assembly
of a multimeric receptor may be necessary to accommo-
date multimeric propeptide binding. Recruitment of addi-
tional cytosolic factors may also contribute to the long
half-time of API import.
Others have suggested that API uses a translocation
mechanism to enter the vacuole (Seguí-Real et al., 1995).
In this model, precursor API binds to the membrane as a
monomer and inserts its propeptide extension into the vac-
uolar membrane before membrane translocation. Our cur-
rent findings indicate that precursor API binds to the mem-
brane as a fully assembled dodecamer rather than as a
monomer. In order for membrane-bound API dodecamer
to enter the vacuole through a protein channel, a disas-
sembly of the oligomeric complex into partially unfolded
monomers would be necessary before translocation into
the vacuole. However, examination of the oligomeric state of
API during membrane transport indicates that the dodecameric
conformation is maintained throughout the import pro-
cess. The precursor is directly processed to the mature hy-
drolase without the appearance of a kinetic intermediate
API form as proposed by others (Seguí-Real et al., 1995).
The sheer size of the membrane-bound oligomeric precur-
sor and the instability of monomeric API make unlikely its
passage into the vacuole by known posttranslational, trans-
location mechanisms.
The transport of oligomeric API across the vacuolar
membrane is consistent with a vesicle-mediated mechanism.
Vesicle-mediated transport events, including vacuolar ves-
icle fusion, are dependent on GTP-binding proteins (Ze-
rial and Stenmark, 1993; Nuoffer and Balch, 1994; Stack
et al., 1995). The finding that in vitro import of API is in-
hibited by nonhydrolyzable GTP analogues suggests a role
for GTPases and the potential participation of vesicle in-
termediates in the Cvt pathway (Scott and Klionsky, 1995).
We are currently characterizing vesicular intermediates
that mediate API transport (Scott, S.V., and D.J. Klion-
sky, manuscript in preparation). From our results, two
models of the API import process can be envisioned.
In the first model, the precursor oligomer binds directly
to the vacuole and enters in an endocytic-like manner (Fig.
7 A). This is followed by the breakdown of the API-con-
taining vesicles and processing of precursor API to the ma-
ture hydrolase. Alternatively, oligomeric precursor API
may initially bind to a prevacuolar compartment before
delivery to the vacuole via transport vesicles. The second
model (Fig. 7 B) is based on the significant genetic overlap
of the Cvt pathway with autophagy, which suggests that
these two routes to the vacuole share largely the same cel-
lular machinery (Harding et al., 1996; Scott et al., 1996).
Specifically, the double-membrane autophagic vesicles (auto-
phagosomes) that nonselectively capture and deliver cyto-
plasmic contents (Baba et al., 1994) to the vacuole may
also be used by precursor API for its transport to this or-
ganelle. However, unlike autophagy, the delivery of API is
constitutive. Thus, a continuous, basal-level supply of au-
tophagic vesicles would be required for the selective deliv-
ery of API to the vacuole. In this model (Fig. 7 B), API
initially binds to putative cusp-shaped progenitors of the
double-membrane autophagosomes (Baba et al., 1994).
Upon enclosure and autophagosome formation, API is
transported to the vacuole, where the outer vesicle mem-
brane fuses with the vacuole, releasing a single-membrane
vesicle into the vacuolar lumen. These vesicles (autophagic
bodies) are then degraded in a PrB-dependent manner
Figure 7. Models for API import via the Cvt pathway. Precursor
API is synthesized and assembled into dodecamers in the cyto-
plasm, followed by membrane binding. During the rate-limiting
step of the pathway, both models A and B propose a vesicle-medi-
ated mechanism of API entry into the vacuole followed by the
breakdown of the API-containing vesicles and cleavage of the
API propeptide in a PrB-dependent manner to yield the mature
hydrolase. The role of molecular chaperones and the location of
the initial binding of precursor API remain to be resolved. (A)
Oligomeric precursor API directly binds to the vacuolar or pre-
vacuolar membrane before the vesicle-mediated entry into the
vacuole. (B) Genetic analyses have revealed a large overlap be-
tween the autophagy and Cvt pathways. In this model, API is de-
livered to the vacuole via double-membrane autophagic vesicles.
Upon reaching the vacuole, these vesicles fuse to the vacuolar
membrane, releasing a single-membrane vesicle (autophagic
body) containing precursor API. This is followed by the break-
down of the vesicles and subsequent processing of the hydrolase
to the mature enzyme.The Journal of Cell Biology, Volume 137, 1997 618
(Takeshige et al., 1992), exposing the oligomeric precursor
API to the vacuolar lumen for processing.
The molecular details of the autophagy and Cvt path-
ways are not well understood. This study places the events
of API oligomerization and import into discrete steps
along the Cvt pathway. A detailed analysis of API import
will help elucidate the molecular basis of both the Cvt and
autophagy pathways.
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